Home › Funds › SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI › ABT

SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI position in ABT

ABBOTT LABORATORIES · Health Care

SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI reported holding 160,174 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$15.8M, representing 1.05% of its reported portfolio and ranking #35 among its reported holdings. SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)160.17K sh
Reported value held$15.83M
Portfolio Weight1.05%
First reportedQ3 2023
Last changeHold
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI's ABT position evolved

SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI first disclosed a stake in ABT in Q3 2023 at 167,267 shares (US$16.2M). The position peaked in Q1 2025 at 161,648 shares, worth US$21.4M. Across 13 filings, SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 160,174 shares valued at US$15.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 167.27K $16.20M New
Q4 2023 166.77K $18.36M Hold
Q1 2024 166.48K $18.92M Hold
Q2 2024 166.10K $17.26M Hold
Q3 2024 168.15K $19.17M Add
Q4 2024 166.30K $18.81M Reduce
Q1 2025 161.65K $21.44M Reduce
Q2 2025 151.72K $20.63M Reduce
Q3 2025 149.15K $19.98M Reduce
Q4 2025 149.72K $18.76M Hold
Q1 2026 152.42K $15.65M Add
Q2 2026 160.88K $14.60M Add
Q3 2026 160.17K $15.83M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI held ABT?

SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI's current position in ABT?

As of Q3 2026, SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI holds 160.17K shares of ABT (ABBOTT LABORATORIES), valued at $15.83M, representing 1.05% of its reported portfolio and ranking #35.

Has SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI been buying or selling ABT?

In the latest 13F filing (Q3 2026), SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI held unchanged its position in ABT. The position peaked in Q1 2025 at 161.65K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.